Professional Documents
Culture Documents
Stelios Respiratory Problems 9.15 PDF
Stelios Respiratory Problems 9.15 PDF
RESPIRATORY GATE
GATE
Chlorine
smallpox
H1N1
Chlorine
Inhaled drugs
PRINCIPLES
PROTEC
T
REMOVE
DECONTAMINATE
Remove and Decontaminate
at the field, or
at the ED facilities.
Victims are contaminated, but usually
they dont contaminate if the
therapist not come in direct contact
with the agent.
agent.
TREAT/TRANSPORT
Treat according the diagnoses, and
the physical condition of the person,
even guided by suspicion and clinical
diagnoses as laboratory investigation
is not always available.
Transport to an appropriate facility if
available
Chemicals agents
Chemicals agents
Latent period
Depending chemical attributes, weather, ecc
Chemical agents
the patient change significantly after
exposure
there are symptoms which BEGAN
(first symptom, even if mild) within 48
hours of a chemical exposure
the first exposure symptom(s) get
better away from exposure
the type of symptom consistent with
the chemical
First symptoms
Lung agents
blister
Nerve
Bronchoconstriction ,
Blood
Biological agents
Why to choose
Easy to obtain - Inexpensive to produce
Potential dissemination over large geographic
area
Creates panic - Can overwhelm medical services
High morbidity and mortality
Difficult to diagnose and/or treat
Some are transmitted person-to-person via
aerosol
Category A
Category B
Coxiella burnetti
(Q fever)
Brucella species
(brucellosis)
Burkholderia mallei
(glanders)
Venezuelan encephalomyelitis
Eastern and Western equine
encephalomyelitis
Ricin toxin from Ricinus communis (castor
beans)
epsilon toxin of Clostridium perfringens
Staphylococcus enterotoxin B
Category C
Nipah virus
Hantavirus
Tickborne hemorrhagic fever viruses
Tickborne encephalitis viruses
Yellow fever
Multi-drug resistant tuberculosis (MDRTB)
Protect
Wash hands and Wear gloves
Use appropriate PPE
Process contaminated material
Clean and disinfect
Prevention
Pre-exposure
active immunization
prophylaxis
identification of threat/use
Incubation period
detection and diagnosis
active and passive immunization
antimicrobial or supportive therapy
Prevention
Obvious disease
diagnosis
treatment
may not be available
may overwhelm system
may be less effective
Common initial
symptoms
Incubation
Period
Anthrax
1-6d
Pneumonic
Plague
(Yersinia
pestis)
pestis)
Stridor
Cough
Dyspnea
1-6 days
Smallpox
(Variola virus)
Headache
Cough
Rash (2-3 days later)
Botulinum
Toxin
(Clostridium
botulinum)
botulinum)
Primary
neurological, delayd
respiratory
(Respiratory Failure
Cyanosis)
1-5 days or
within 24-36
hours if
ingested
Gradual to
progressiv
e
High (60%)
without rapid
treatment or
ventilatory
support
No person-toperson
transmission
Typhoidal
Tularemia
2 to 21 days
acute
Moderate if
untreated (2030%), Low if
treated (5%)
No person-toperson
transmission
Viral
Hemorrhagic
Fever
Fever, Malaise,
Prostration,
Syndromes
INFLUENZA
PULMONARY
4 to 21 d
acute
Moderate to high,
depending from
the specie
Moderate P to P
17d
Onset:
rapid
Rapid
sudden
Lethality:
Transmission
High (80-90%)
Not
transmissible
person to
person
High (90-100%)
without treatment
within 24 hours of
symptoms
High (person
to person)
Moderate
(20-40% in unvac;
3% in rec vacc )
High (person
to person)
Conclusions
Remember